• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
Evaluation of prognostic markers for patients with curatively resected thoracic esophageal squamous cell carcinomas.对接受根治性切除的胸段食管鳞状细胞癌患者的预后标志物评估。
Mol Clin Oncol. 2016 Dec;5(6):767-772. doi: 10.3892/mco.2016.1073. Epub 2016 Nov 2.
2
Clinical Value of Tumor Marker Index Based on Preoperative CYFRA 21-1 and SCC-Ag in the Evaluation of Prognosis and Treatment Effectiveness in Patients with Esophageal Squamous Cell Carcinoma.基于术前细胞角蛋白19片段(CYFRA 21-1)和鳞状细胞癌抗原(SCC-Ag)的肿瘤标志物指标在评估食管鳞状细胞癌患者预后及治疗效果中的临床价值
Onco Targets Ther. 2020 May 13;13:4135-4143. doi: 10.2147/OTT.S243038. eCollection 2020.
3
Glasgow prognostic score and neutrophil-lymphocyte ratio are good prognostic indicators after radical neck dissection for advanced squamous cell carcinoma in the hypopharynx.格拉斯哥预后评分和中性粒细胞与淋巴细胞比值是下咽晚期鳞状细胞癌根治性颈清扫术后良好的预后指标。
Langenbecks Arch Surg. 2016 Sep;401(6):861-6. doi: 10.1007/s00423-016-1453-9. Epub 2016 May 28.
4
Tumor marker index based on preoperative SCC and CYFRA 21-1 is a significant prognostic factor for patients with resectable esophageal squamous cell carcinoma.基于术前 SCC 和 CYFRA 21-1 的肿瘤标志物指数是可切除食管鳞癌患者的重要预后因素。
Cancer Biomark. 2019;25(3):243-250. doi: 10.3233/CBM-190058.
5
Prognostic Benefits of Thoracoscopic Esophagectomy for Thoracic Esophageal Squamous Cell Carcinomas.胸腔镜食管切除术对胸段食管鳞状细胞癌的预后益处
Chirurgia (Bucur). 2016 Jul-Aug;111(4):313-7.
6
Inflammation-based prognostic system predicts postoperative survival of esophageal carcinoma patients with normal preoperative serum carcinoembryonic antigen and squamous cell carcinoma antigen levels.基于炎症的预后系统可预测术前血清癌胚抗原和鳞状细胞癌抗原水平正常的食管癌患者的术后生存率。
World J Surg Oncol. 2016 May 5;14:141. doi: 10.1186/s12957-016-0878-5.
7
The pretreatment Controlling Nutritional Status (CONUT) score is an independent prognostic factor in patients with resectable thoracic esophageal squamous cell carcinoma: results from a retrospective study.术前控制营养状况(CONUT)评分是可切除胸段食管鳞状细胞癌患者的独立预后因素:一项回顾性研究结果
BMC Cancer. 2016 Sep 6;16(1):722. doi: 10.1186/s12885-016-2696-0.
8
The predictive value of a preoperative systemic immune-inflammation index and prognostic nutritional index in patients with esophageal squamous cell carcinoma.术前全身免疫炎症指数和预后营养指数对食管鳞癌患者的预测价值。
J Cell Physiol. 2019 Feb;234(2):1794-1802. doi: 10.1002/jcp.27052. Epub 2018 Aug 2.
9
Platelet-to-Lymphocyte Ratio Multiplied by the Cytokeratin-19 Fragment Level as a Predictor of Pathological Response to Neoadjuvant Chemotherapy in Esophageal Squamous Cell Carcinoma.血小板与淋巴细胞比值乘以细胞角蛋白-19片段水平作为食管鳞状细胞癌新辅助化疗病理反应的预测指标
Yonago Acta Med. 2021 Aug 24;64(3):249-259. doi: 10.33160/yam.2021.08.003. eCollection 2021 Aug.
10
Pretreatment serum CYFRA 21-1 level correlates significantly with survival of cervical cancer patients: a multivariate analysis of 506 cases.治疗前血清CYFRA 21-1水平与宫颈癌患者生存率显著相关:506例病例的多因素分析
Gynecol Oncol. 2015 Jul;138(1):89-93. doi: 10.1016/j.ygyno.2015.04.012. Epub 2015 Apr 22.

引用本文的文献

1
Association between preoperative neutrophil-to-lymphocyte ratio and the survival outcomes of esophageal cancer patients underwent esophagectomy: a systematic review and meta-analysis.术前中性粒细胞与淋巴细胞比值与接受食管癌切除术的患者生存结局之间的关联:一项系统评价和荟萃分析
Front Oncol. 2024 Aug 19;14:1404711. doi: 10.3389/fonc.2024.1404711. eCollection 2024.
2
Real-world retrospective study of anti-PD-1 antibody in combination with chemotherapy as a neoadjuvant treatment strategy for locally advanced resectable esophageal squamous cell carcinoma.抗程序性死亡蛋白1(PD-1)抗体联合化疗作为局部晚期可切除食管鳞状细胞癌新辅助治疗策略的真实世界回顾性研究
J Thorac Dis. 2024 Jul 30;16(7):4106-4119. doi: 10.21037/jtd-24-169. Epub 2024 Jul 22.
3
The role of microbiota in esophageal squamous cell carcinoma: A review of the literature.微生物群在食管鳞状细胞癌中的作用:文献综述。
Thorac Cancer. 2023 Oct;14(28):2821-2829. doi: 10.1111/1759-7714.15096. Epub 2023 Sep 7.
4
Development and validation of a novel pre-operative comprehensive prognostic score in esophageal squamous cell carcinoma.一种新型食管鳞癌术前综合预后评分的建立与验证。
Bosn J Basic Med Sci. 2022 Jun 1;22(3):460-470. doi: 10.17305/bjbms.2021.6350.
5
Perioperative Predictive Markers for Recurrence of Esophageal Cancer after Esophagectomy.食管癌切除术后复发的围手术期预测标志物
Gastrointest Tumors. 2021 Apr;8(2):87-95. doi: 10.1159/000513961. Epub 2021 Mar 17.
6
Diagnostic Immunostaining and Tumor Markers Predict the Prognosis of Esophageal Neuroendocrine Cell Carcinoma Patients.诊断免疫组化和肿瘤标志物预测食管神经内分泌细胞癌患者的预后。
Ann Surg Oncol. 2021 Nov;28(12):7983-7989. doi: 10.1245/s10434-021-09872-5. Epub 2021 Apr 11.
7
Prognostic Significance of the Combination of Fibrinogen and Tumor Marker Index in Esophageal Squamous Cell Carcinoma Patients.纤维蛋白原与肿瘤标志物指标联合检测在食管鳞状细胞癌患者中的预后意义
Onco Targets Ther. 2021 Feb 17;14:1101-1111. doi: 10.2147/OTT.S278831. eCollection 2021.
8
Prognostic significance of systemic inflammatory markers in esophageal cancer: Systematic review and meta-analysis.食管癌全身炎症标志物的预后意义:系统评价与Meta分析
Ann Gastroenterol Surg. 2019 Oct 21;4(1):56-63. doi: 10.1002/ags3.12294. eCollection 2020 Jan.
9
Neutrophil-to-lymphocyte ratio as prognostic marker in esophageal cancer: a systematic review and meta-analysis.中性粒细胞与淋巴细胞比值作为食管癌预后标志物的系统评价和荟萃分析
J Thorac Dis. 2019 Jul;11(7):3136-3145. doi: 10.21037/jtd.2019.07.30.
10
Clinical use of tumor biomarkers in prediction for prognosis and chemotherapeutic effect in esophageal squamous cell carcinoma.肿瘤标志物在预测食管鳞癌预后和化疗效果中的临床应用。
BMC Cancer. 2019 May 31;19(1):526. doi: 10.1186/s12885-019-5755-5.

本文引用的文献

1
Prognostic Significance of Neutrophil-to-Lymphocyte Ratio and Platelet-to-Lymphocyte Ratio in Oncologic Outcomes of Esophageal Cancer: A Systematic Review and Meta-analysis.中性粒细胞与淋巴细胞比值及血小板与淋巴细胞比值对食管癌肿瘤学结局的预后意义:一项系统评价和Meta分析
Ann Surg Oncol. 2016 Feb;23(2):646-54. doi: 10.1245/s10434-015-4869-5. Epub 2015 Sep 28.
2
CYFRA 21.1 in bronchoalveolar lavage of idiopathic pulmonary fibrosis patients.细胞角蛋白片段21.1在特发性肺纤维化患者支气管肺泡灌洗中的情况
Exp Lung Res. 2015;41(8):459-65. doi: 10.3109/01902148.2015.1073407.
3
Pre-treatment neutrophil-to-lymphocyte ratio is associated with neutrophil and T-cell infiltration and predicts clinical outcome in patients with glioblastoma.治疗前中性粒细胞与淋巴细胞比值与中性粒细胞和T细胞浸润相关,并可预测胶质母细胞瘤患者的临床结局。
BMC Cancer. 2015 Sep 4;15:617. doi: 10.1186/s12885-015-1629-7.
4
A nomogram to predict prognostic values of various inflammatory biomarkers in patients with esophageal squamous cell carcinoma.一种用于预测食管鳞状细胞癌患者各种炎症生物标志物预后价值的列线图。
Am J Cancer Res. 2015 Jun 15;5(7):2180-9. eCollection 2015.
5
Impact of inflammation-based prognostic score on survival after curative thoracoscopic esophagectomy for esophageal cancer.基于炎症的预后评分对食管癌根治性胸腔镜食管切除术后生存的影响。
Eur J Surg Oncol. 2015 Oct;41(10):1308-15. doi: 10.1016/j.ejso.2015.07.008. Epub 2015 Jul 30.
6
Prognostic role of neutrophil-lymphocyte ratio in operable esophageal squamous cell carcinoma.中性粒细胞与淋巴细胞比值在可手术切除食管鳞状细胞癌中的预后作用
World J Gastroenterol. 2015 May 14;21(18):5591-7. doi: 10.3748/wjg.v21.i18.5591.
7
Inflammation-based prognostic scores and nutritional prognostic index in patients with locally-advanced unresectable colorectal cancer.局部晚期不可切除结直肠癌患者基于炎症的预后评分和营养预后指数
World J Surg Oncol. 2014 Jul 15;12:210. doi: 10.1186/1477-7819-12-210.
8
Surgical indications and optimization of patients for resectable esophageal malignancies.可切除食管恶性肿瘤患者的手术指征及优化
J Thorac Dis. 2014 Mar;6(3):249-57. doi: 10.3978/j.issn.2072-1439.2013.11.18.
9
Comparison of the prognostic values of various nutritional parameters in patients with esophageal squamous cell carcinoma from Southern China.中国南方地区食管鳞癌患者各种营养参数预后价值的比较。
J Thorac Dis. 2013 Aug;5(4):484-91. doi: 10.3978/j.issn.2072-1439.2013.08.38.
10
Modified Glasgow prognostic score in patients with incurable stage IV colorectal cancer.不可治愈的 IV 期结直肠癌患者的改良格拉斯哥预后评分。
Am J Surg. 2013 Aug;206(2):234-40. doi: 10.1016/j.amjsurg.2012.07.051. Epub 2013 Jul 1.

对接受根治性切除的胸段食管鳞状细胞癌患者的预后标志物评估。

Evaluation of prognostic markers for patients with curatively resected thoracic esophageal squamous cell carcinomas.

作者信息

Ikeguchi Masahide, Kouno Yusuke, Kihara Kyoichi, Suzuki Kazunori, Endo Kanenori, Nakamura Seiichi, Sawada Takashi, Shimizu Tetsu, Matsunaga Tomoyuki, Fukumoto Yoji, Saito Hiroaki

机构信息

Department of Surgery, Τottori Prefectural Central Hospital, Tottori 680-0901, Japan.

Department of Surgery, Division of Surgical Oncology, Faculty of Medicine, Tottori University, Yonago 683-8504, Japan.

出版信息

Mol Clin Oncol. 2016 Dec;5(6):767-772. doi: 10.3892/mco.2016.1073. Epub 2016 Nov 2.

DOI:10.3892/mco.2016.1073
PMID:28105355
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC5228547/
Abstract

The Glasgow Prognostic Score (GPS), neutrophil/lymphocyte ratio (NLR) and prognostic nutritional index (PNI) are prognostic parameters for malignancies. Additionally, serum squamous cell carcinoma antigen (SCC-Ag) and cytokeratin 19 fragments (CYFRA 21-1) are tumor markers for squamous cell carcinoma. In the present study, the prognostic importance of these markers in patients with resectable thoracic esophageal cancer was investigated. In this retrospective study, 84 enrolled patients diagnosed with resectable clinical stage I-III thoracic esophageal squamous cell carcinomas (ESCCs) underwent thoracic esophageal resection and three-field lymph node dissection at Tottori University Hospital between January 2007 and December 2013. The correlations among preoperative patient markers (GPS, NLR, PNI, SCC-Ag and CYFRA 21-1) and the occurrence of postoperative complications and patient survival were analyzed. The operative mortality was 2.4%, and morbidity was 42.9%. Strong correlations between occurrence of postoperative complications and open thoracotomy (P=0.083) and high-serum CYFRA 21-1 (P=0.007) were observed. In 15 patients with high-serum CYFRA 21-1, postoperative complications were detected in 11 of them (73.3%); on the other hand, complications occurred in 25 of 69 (36.2%) with low-serum CYFRA 21-1. The 5-year disease-free survival rate and 5-year overall survival rate of all the patients were 52.2 and 50.8%, respectively. Among the prognostic parameters, preoperative high NLR was determined to be a poor prognostic factor, independent of the tumor stage in the multivariate analysis. These results may indicate that, in patients with preoperative high-serum CYFRA 21-1, more attention should be paid to the occurrence of postoperative complications. Therefore, in such cases, anastomosis between blood vessels of the substitute esophagus and cervical vessels would be recommended. Furthermore, in patients with high preoperative NLR, effective adjuvant chemoradiotherapy should be considered to prolong the patients' survival, even of stage I or II patients.

摘要

格拉斯哥预后评分(GPS)、中性粒细胞/淋巴细胞比值(NLR)和预后营养指数(PNI)是恶性肿瘤的预后参数。此外,血清鳞状细胞癌抗原(SCC-Ag)和细胞角蛋白19片段(CYFRA 21-1)是鳞状细胞癌的肿瘤标志物。在本研究中,调查了这些标志物在可切除胸段食管癌患者中的预后重要性。在这项回顾性研究中,2007年1月至2013年12月期间,84例确诊为可切除临床I-III期胸段食管鳞状细胞癌(ESCC)的入组患者在鸟取大学医院接受了胸段食管切除术和三野淋巴结清扫术。分析了术前患者标志物(GPS、NLR、PNI、SCC-Ag和CYFRA 21-1)与术后并发症发生情况及患者生存之间的相关性。手术死亡率为2.4%,发病率为42.9%。观察到术后并发症的发生与开胸手术(P=0.083)和高血清CYFRA 21-1(P=0.007)之间存在强相关性。在15例高血清CYFRA 21-1患者中,其中11例(73.3%)检测到术后并发症;另一方面,低血清CYFRA 21-1的69例中有25例(36.2%)发生并发症。所有患者的5年无病生存率和5年总生存率分别为52.2%和50.8%。在预后参数中,术前高NLR被确定为不良预后因素,在多因素分析中独立于肿瘤分期。这些结果可能表明,对于术前高血清CYFRA 21-1的患者,应更关注术后并发症的发生。因此,在这种情况下,建议在替代食管血管与颈血管之间进行吻合。此外,对于术前NLR高的患者,即使是I期或II期患者,也应考虑有效的辅助放化疗以延长患者生存。